Journals / Türk Pediatri Arşivi / 2014 / Cilt: 49 - Sayı: 2

Vasoactive intestinal peptide releasing tumor which caused to chronic watery diarrhea and hypokalemia

Kronik sulu ishal ve hipokalemiye neden olan vazoaktif intestinal polipeptit salgılayan tümör

Pages
160–162
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient was diagnosed with va- soactive intestinal peptide releasing ganglioneuroblastoma localized in the right surrenal gland. (Türk Ped Arş 2014; 49: 160-2)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Watery diarrhea, hypokalemia and achlorhydria syndrome is a rare cause of chronic secretory diarrhea arising from a vasoactive intes- tinal peptide releasing tumor.
📊
Key Findings & Data:In this article, a 15-month old female patient with watery diarrhea and abdominal distension which lasting four months is presented.
💡
Conclusion & Impact:The patient was diagnosed with va- soactive intestinal peptide releasing ganglioneuroblastoma localized in the right surrenal gland. (Türk Ped Arş 2014; 49: 160-2)
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Watery diarrhea, hypokalemia and achlorhydria syndrome is a rare cause of chronic secretory diarrhea arising from a vasoactive intes- tinal peptide releasing tumor. In this article, a 15-month old female patient with watery diarrhea and abdominal distension which lasting four months is presented. In different centers no diagnosis could be made although investigations. The patient was diagnosed with va- soactive intestinal peptide releasing ganglioneuroblastoma localized in the right surrenal gland. (Türk Ped Arş 2014; 49: 160-2)

Özet

Sulu ishal, hipokalemi ve aklorhidri sendromu, vazoaktif intestinal peptit üreten bir tümörün neden olduğu kronik sekretuvar isha- lin nadir bir nedenidir. Bu yazıda dört aydır sulu ishal, karın şişliği nedeniyle çeşitli merkezlerde araştırılmasına rağmen tanı konula- mamış, vazoaktif intestinal peptit salgılayan sağ sürrenal yerleşimli gangliyonöroblastom tanısı alan 15 aylık bir kız olgu sunulmuştur. (Türk Ped Arş 2014; 49: 160-2)

🔖

Cite This Article

KANIK, A., ÖZDEMİR, T., BARAN, M., ELİAÇIK, K., HELVACI, M., ÇEÇEN, E., ÇAYAN, Ö. (2022). Vasoactive intestinal peptide releasing tumor which caused to chronic watery diarrhea and hypokalemia. Türk Pediatri Arşivi, Cilt: 49 - Sayı: 2, 160–162. https://ajindex.com/articles/641206

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Verner JV, Morrison A. Islet cell tumour and a syndrome of ref- ractory watery diarrhea and hypokalemia. Am J Med 1958; 29: 529. Petersom HD, Collins OD. Chronic diarrhea and failure to thri- ve secondary to ganglioneuroma. Arch Surg 1967; 6: 934-6. [CrossRef] Marks IN, Bank S, Louw JH, Farman J. Islet cell tumor of the pancreas with reversible watery diarrhoea and achlorhydria. Gastroenterology 1967; 52: 695-708.
  2. Murphy MS, Sibal A, Mann JR. Persistent diarrhea and occult vipomas in children. Br Med J 2000; 320: 1524-6. [CrossRef] Forte LR, Thorne PK, Eber SL, et al. Stimulation of intestinal Cl-transport by heat-stable enterotoxin: activation of cAMP- dependent protein kinase by cGMP. Am J Physiol 1992; 263: C607-15. Zhang WQ, Liu JF, Zhao J, Zhao SY, Xue Y. Tumor with watery diarrhoea, hypokalaemia in a 3-year-old girl. Eur J Pediatr 2009; 168: 859-62. [CrossRef] Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic ne- uroendocine tumours. Lancet Oncol 2008; 9: 61-72. [CrossRef] Quak SH, Prabhakaran K, Kwok R, O’Reilly AP. Vasoactive intes- tinal peptide secreting tumours in children: a case report with literatüre review. Aust Pediatr J 1988; 24: 55-8.
  3. Yamaguchi K, Abe K, Otsubo K, et al. The WDHA syndrome: Cli- nical and laboratory data on 28 Japanese cases. Peptides 1984; 5: 415-21. [CrossRef] Melen-Mucha G, Lawnicka H, Kierszniewska-Stepien D, Komo- rowski J, Stepien H. The place of somatostatin analogs in the di- agnosis and treatment of the neuoroendocrine glands tumors. Recent Patents Anticancer Drug Discov 2006; 2: 237-54. [CrossRef]